Both are top healing peptides. Both reduce inflammation. But they work through completely different pathways. Here is the full breakdown so you can choose the right one, or learn why the best answer might be both.
BPC-157 and TB-500 both promote healing and reduce inflammation, but they do it through completely different biological pathways. Understanding how each one works helps you choose the right tool for your specific situation.
| Feature | BPC-157 | TB-500 |
|---|---|---|
| Primary Healing Mechanism | Angiogenesis + collagen synthesis | Actin upregulation + cell migration |
| Systemic vs. Localized Action | Localized (best near injury) | Systemic (whole-body effect) |
| Gut Health Benefits | ||
| Flexibility & Muscle Stiffness | ||
| Neuroprotective Effects | ||
| Cardiac Tissue Repair | ||
| Oral Bioavailability | ||
| Synergistic When Combined |
Each peptide has areas where it clearly outperforms the other. Here is an honest breakdown across the most important categories.
The right choice depends on your specific goals and situation. Here is a practical guide to help you decide.
The Wolverine Stack combines BPC-157 and TB-500 to get the best of both worlds. BPC-157 handles the localized, structural repair while TB-500 provides systemic support and reduces whole-body inflammation. Together, they cover every angle of the healing process.
Neither BPC-157 nor TB-500 is FDA approved for human use. Both are research compounds. This protocol is provided for educational purposes only. Always consult a qualified healthcare provider before beginning any peptide protocol.
| Aspect | BPC-157 | TB-500 |
|---|---|---|
| Typical Dose | 500 mcg–1 mg | 2–2.5 mg |
| Frequency | Once daily | Twice weekly (loading), once weekly (maintenance) |
| Route | Subcutaneous (near injury) or oral | Subcutaneous or intramuscular |
| Cycle Length | 4–12 weeks | 4–6 weeks loading, then maintenance |
| Oral Option | Yes (for gut health) | No (injection only) |
| Site-Specific Injection | Recommended near injury | Not required — systemic action |
| Can Be Combined | Yes — stack with TB-500 | Yes — stack with BPC-157 |
Both peptides have a favorable safety profile in preclinical research, with most side effects being mild and temporary. Neither has long-term human safety data.
| Side Effect | BPC-157 | TB-500 |
|---|---|---|
| Nausea | Rare, mild | Rare |
| Dizziness / Head Rush | Rare | Occasional (especially first injection) |
| Injection Site Reactions | Mild, temporary | Mild, temporary |
| Fatigue | Not reported | Temporary, early in cycle |
| Tumor Growth Concern | Not reported | Theoretical (not confirmed in humans) |
| Anticoagulant Interaction | Possible — monitor if on blood thinners | Not reported |
| Long-term Safety Data | Limited (preclinical only) | Limited (preclinical only) |
Not sure which peptide fits your situation? Answer 7 quick questions and get a personalized recommendation based on your goals, injury type, and preferences.
Answer 7 quick questions and we will recommend BPC-157, TB-500, or the Wolverine Stack based on your specific situation.
The most common questions people have when comparing BPC-157 and TB-500.
Complete dosing guide, reconstitution instructions, all research references, and a full FAQ for BPC-157.
Complete dosing guide, reconstitution instructions, all research references, and a full FAQ for TB-500.